Company intelligence / Profile preview

PhenomeX

Emeryville, California, United States

Ownership: Private
Employees: ~51
Development stage: Other

Overview

PhenomeX built and commercialized high-throughput single-cell analysis instruments (not drugs or biologics), enabling advances in antibody discovery, cell and gene therapy development, and cell line engineering. The platforms have been widely adopted in research and clinical development, supporting top pharmaceutical R&D.

Therapeutic areas: ImmunologyInfectious DiseasesOtherOncologyNeurology
Modalities: BiologicCell therapyGene therapy
Industry: Non-Drug Biotech

Partnerships

Top 15 pharmaceutical companies (customers)85% of leading US cancer centers (customers)

Beyond the preview

Go deeper on PhenomeX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PhenomeX.

Explore the full profile